# A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults

> **NCT03966040** · PHASE1 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 144 (actual)

## Conditions studied

- Staphylococcus Aureus Infection

## Interventions

- **BIOLOGICAL:** Inoculate Staphylococcus aureus vaccine(Escherichia Coli) at day 0-3-7
- **BIOLOGICAL:** Inoculate Staphylococcus aureus vaccine(Escherichia Coli) at day 0/0-3-7
- **BIOLOGICAL:** Inoculate Staphylococcus aureus vaccine(Escherichia Coli) at day 0/0-7
- **BIOLOGICAL:** Inoculate Staphylococcus aureus vaccine(Escherichia Coli) at day 0/0-7-14

## Key facts

- **NCT ID:** NCT03966040
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-16
- **Primary completion:** 2019-12-16
- **Final completion:** 2020-05-16
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2021-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03966040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03966040, "A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03966040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*